Literature DB >> 25826521

Velamentous insertion of the umbilical cord vessels with vasa praevia--a case report.

Mirela Anişoara Siminel1, Cristian Gheonea, Mihail Relu Stănescu, Alexandru Cristian Comănescu, Anda Lorena Dijmărescu, Simona Daniela NeamŢu, Bogdan Virgil Cotoi, Ramona Mihaela NedelcuŢă, Elena Carmen Niculescu.   

Abstract

Among the abnormal cord insertion pathology, velamentous cord insertion associated with rupture of vasa praevia is the most severe condition related to the outcome of the newborn. In velamentous cord insertion, the fetal vessels run freely through the fetal membranes without protection from Wharton's jelly, umbilical vessels diverging as they traverse the membranes. When the membranes are ruptured, complete tearing of fetal vessels through the torn membranes or partial rupture near the site of membrane rupture may occur. Velamentous insertion occurs in approximately 1% of singleton gestations, but is observed in as many as 15% of monochorionic twin gestations. The risk of perinatal death was doubled in pregnancies with velamentous cord insertion relative to normal cord insertion. This condition can be diagnosed by ultrasonography with a sensitivity of 67% and specificity of 100% in the second trimester. We report a case of a newborn who came from a velamentous cord insertion condition associated with rupture of vasa praevia after the spontaneously membranes rupture. After a difficult resuscitation and stabilization, the newborn survived with a good outcome after the follow-up.

Entities:  

Mesh:

Year:  2015        PMID: 25826521

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  1 in total

1.  The role of mediating factors involved in angiogenesis during implantation.

Authors:  Lidia Boldeanu; Anda Lorena Dijmărescu; Mirela Radu; Cristian Adrian Siloşi; Mircea Vasile Popescu-Drigă; Ioan Sabin Poenariu; Isabela Siloşi; Mihail Virgil Boldeanu; Marius Bogdan Novac; Liliana Victoria Novac
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.